The Business Times
SUBSCRIBERS

Pfizer sues Johnson & Johnson over anti-competitive tactics

It claims J&J acted to squash its cheaper version of powerful rheumatoid arthritis drug

Published Thu, Sep 21, 2017 · 09:50 PM

Washington

A LEGAL brawl between two of the world's largest drug companies could shape the future of a nascent market of copycat drugs that are intended to bring down the cost of the most advanced and expensive medicines.

Pfizer filed a lawsuit on Wednesday against fellow pharmaceutical giant Johnson & Johnson for using "anti-competitive" tactics to squash its cheaper version of a powerful rheumatoid arthritis drug.

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here